Korsana Biosciences, Inc. (KRSA) vs Ocular Therapeutix, Inc. (OCUL)
- Korsana Biosciences, Inc. KRSA 32.38 −3.77%
- Ocular Therapeutix, Inc. OCUL 6.87 −6.91%
Korsana Biosciences, Inc. and Ocular Therapeutix, Inc. are both Biotechnology companies. Korsana Biosciences, Inc. and Ocular Therapeutix, Inc. are of similar size ($1.6B and $1.5B). Korsana Biosciences, Inc. grew revenue faster over the last twelve months: 30.8% against −8.14%. Korsana Biosciences, Inc. has the higher net margin (0.00% vs −579.1%) and the lower return on invested capital (−115.4% vs 0.00%). Across the 18 metrics below, Korsana Biosciences, Inc. leads on 10 and Ocular Therapeutix, Inc. on 8.
Valuation
Profitability
| Metric | KRSA | OCUL | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 87.11% | 65.16% |
| Operating margin | 0.00% | (603.04%) | 0.00% |
| Net margin | 0.00% | (579.10%) | 0.00% |
| Free cash flow margin | 0.00% | (490.07%) | 0.00% |
| Return on equity | (98.22%) | (72.99%) | (56.36%) |
| Return on assets | (82.29%) | (53.70%) | (48.04%) |
| Return on invested capital | (115.40%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack